Vitespen Active Not Recruiting Phase 2 Trials for Recurrent Glioblastoma / Recurrent Adult Brain Tumor / Gliosarcoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01814813Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery